ASIC points to four-year delay on OTC derivatives
It will be four years before the Australian Securities and Investments Commission (ASIC) will be fully resourced to extend its market analysis system to monitor wholesale over the counter (OTC) derivatives.
The regulator told a Parliamentary Committee that the delay in being able to deal with OTC derivatives was a funding and staffing issue.
Answering a question on notice from the Parliamentary Joint Committee on Corporations and Financial Services, ASIC said its present estimate was that the system, human resources and implementation requirements for extending its market analysis system to encompass wholesale OTC products would cost around $9.9 million.
It said this would need to be supported by increases to the regulator’s staff numbers to undertake related surveillances and enquiries, as well as provide specialised training for staff.
“We estimate that it will cost around $19 million in total over a period of four years for ASIC to adequately develop its capabilities for the oversight of OTC markets,” the ASIC answer said.
AUTHOR
Mike Taylor
Recommended for you
Government has introduced a bill to Parliament to legislate the first stream of the QAR reforms.
ASIC now has a 1:1 ratio when it comes to court success in the enforcement of crypto activities and more action is expected as Treasury seeks to introduce a regulatory framework.
A leading governance body has hit out at “specialist interest groups proposing ad hoc law reform” when it comes to reforms of financial services legislation and believes an independent body is needed.
The release of ALRC’s final report into financial services legislation has highlighted financial advice as a “significant” focus as it seeks to reduce costs and help advisers understand their obligations, alongside the Quality of Advice Review.
